Halozyme Therapeutics IncNASDAQ:HALO
- LAST PRICE42.7800
- TODAY'S CHANGE (%)-1.0400 (-2.3733%)
- Bid / Lots42.7700/ 2
- Ask / Lots42.7900/ 2
- Open / Previous Close43.8000 / 43.8200
- Day Range
- 52 Week Range
- Volume641,580
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HALO |
|---|---|---|
| 09:32 ET | 5602 | 43.805 |
| 09:34 ET | 800 | 43.9475 |
| 09:36 ET | 3052 | 43.54 |
| 09:38 ET | 1600 | 43.71 |
| 09:39 ET | 1200 | 43.745 |
| 09:41 ET | 400 | 43.74 |
| 09:43 ET | 100 | 43.65 |
| 09:45 ET | 2630 | 43.55 |
| 09:48 ET | 2100 | 43.63 |
| 09:50 ET | 1100 | 43.725 |
| 09:52 ET | 1527 | 43.73 |
| 09:54 ET | 900 | 43.65 |
| 09:56 ET | 3744 | 43.655 |
| 09:57 ET | 1700 | 43.54 |
| 09:59 ET | 5125 | 43.51 |
| 10:01 ET | 1414 | 43.54 |
| 10:03 ET | 2607 | 43.445 |
| 10:06 ET | 1922 | 43.395 |
| 10:08 ET | 1673 | 43.31 |
| 10:10 ET | 500 | 43.28 |
| 10:12 ET | 1700 | 43.395 |
| 10:14 ET | 500 | 43.4 |
| 10:15 ET | 1800 | 43.33 |
| 10:17 ET | 3045 | 43.23 |
| 10:19 ET | 400 | 43.3 |
| 10:21 ET | 4551 | 43.17 |
| 10:24 ET | 6087 | 43.24 |
| 10:26 ET | 5884 | 43.22 |
| 10:28 ET | 2700 | 43.17 |
| 10:30 ET | 2359 | 43.12 |
| 10:32 ET | 4480 | 43.17 |
| 10:33 ET | 2310 | 43.24 |
| 10:35 ET | 500 | 43.335 |
| 10:37 ET | 1859 | 43.31 |
| 10:39 ET | 1237 | 43.31 |
| 10:42 ET | 2106 | 43.24 |
| 10:44 ET | 2500 | 43.18 |
| 10:46 ET | 2800 | 43.27 |
| 10:48 ET | 1700 | 43.305 |
| 10:50 ET | 1200 | 43.36 |
| 10:51 ET | 3100 | 43.375 |
| 10:53 ET | 7391 | 43.345 |
| 10:55 ET | 12286 | 43.35 |
| 10:57 ET | 2800 | 43.4 |
| 11:00 ET | 2726 | 43.48 |
| 11:02 ET | 7013 | 43.41 |
| 11:04 ET | 1800 | 43.43 |
| 11:06 ET | 700 | 43.4035 |
| 11:08 ET | 2600 | 43.48 |
| 11:09 ET | 1044 | 43.4575 |
| 11:11 ET | 1120 | 43.42 |
| 11:13 ET | 2729 | 43.455 |
| 11:15 ET | 2450 | 43.51 |
| 11:18 ET | 3357 | 43.46 |
| 11:20 ET | 1700 | 43.405 |
| 11:22 ET | 1016 | 43.4 |
| 11:24 ET | 3333 | 43.37 |
| 11:26 ET | 380 | 43.355 |
| 11:27 ET | 300 | 43.34 |
| 11:29 ET | 1504 | 43.39 |
| 11:31 ET | 500 | 43.39 |
| 11:33 ET | 4726 | 43.375 |
| 11:36 ET | 1750 | 43.48 |
| 11:38 ET | 876 | 43.525 |
| 11:40 ET | 800 | 43.56 |
| 11:42 ET | 815 | 43.59 |
| 11:44 ET | 900 | 43.63 |
| 11:45 ET | 1806 | 43.56 |
| 11:47 ET | 100 | 43.56 |
| 11:49 ET | 3122 | 43.48 |
| 11:51 ET | 630 | 43.45 |
| 11:54 ET | 800 | 43.42 |
| 11:56 ET | 300 | 43.36 |
| 11:58 ET | 300 | 43.36 |
| 12:00 ET | 400 | 43.405 |
| 12:02 ET | 500 | 43.39 |
| 12:03 ET | 300 | 43.405 |
| 12:05 ET | 300 | 43.42 |
| 12:07 ET | 2351 | 43.405 |
| 12:09 ET | 4582 | 43.37 |
| 12:12 ET | 600 | 43.37 |
| 12:14 ET | 2431 | 43.39 |
| 12:16 ET | 978 | 43.3975 |
| 12:18 ET | 300 | 43.3975 |
| 12:20 ET | 9335 | 43.42 |
| 12:21 ET | 4805 | 43.32 |
| 12:23 ET | 8429 | 43.32 |
| 12:25 ET | 310 | 43.34 |
| 12:27 ET | 230 | 43.34 |
| 12:30 ET | 500 | 43.36 |
| 12:32 ET | 750 | 43.3201 |
| 12:34 ET | 965 | 43.36 |
| 12:36 ET | 700 | 43.4 |
| 12:38 ET | 300 | 43.39 |
| 12:39 ET | 2322 | 43.39 |
| 12:41 ET | 334 | 43.3844 |
| 12:43 ET | 1000 | 43.385 |
| 12:45 ET | 2500 | 43.35 |
| 12:48 ET | 1590 | 43.42 |
| 12:50 ET | 1776 | 43.35 |
| 12:52 ET | 1398 | 43.2806 |
| 12:56 ET | 800 | 43.32 |
| 12:57 ET | 800 | 43.33 |
| 12:59 ET | 552 | 43.33 |
| 01:01 ET | 2400 | 43.3 |
| 01:03 ET | 1750 | 43.26 |
| 01:06 ET | 800 | 43.295 |
| 01:08 ET | 824 | 43.33 |
| 01:10 ET | 600 | 43.36 |
| 01:12 ET | 700 | 43.37 |
| 01:14 ET | 1300 | 43.4 |
| 01:15 ET | 300 | 43.44 |
| 01:17 ET | 600 | 43.4 |
| 01:19 ET | 4229 | 43.35 |
| 01:21 ET | 112 | 43.32 |
| 01:24 ET | 245 | 43.345 |
| 01:26 ET | 2457 | 43.33 |
| 01:30 ET | 400 | 43.345 |
| 01:32 ET | 300 | 43.32 |
| 01:33 ET | 100 | 43.35 |
| 01:35 ET | 200 | 43.34 |
| 01:37 ET | 400 | 43.35 |
| 01:39 ET | 1127 | 43.34 |
| 01:42 ET | 943 | 43.31 |
| 01:44 ET | 1708 | 43.265 |
| 01:46 ET | 450 | 43.255 |
| 01:48 ET | 3732 | 43.23 |
| 01:50 ET | 400 | 43.28 |
| 01:51 ET | 1157 | 43.29 |
| 01:53 ET | 1520 | 43.27 |
| 01:55 ET | 200 | 43.25 |
| 01:57 ET | 800 | 43.275 |
| 02:00 ET | 1600 | 43.26 |
| 02:02 ET | 600 | 43.25 |
| 02:04 ET | 300 | 43.24 |
| 02:06 ET | 2202 | 43.16 |
| 02:08 ET | 4556 | 43.24 |
| 02:09 ET | 3100 | 43.17 |
| 02:11 ET | 846 | 43.2 |
| 02:13 ET | 702 | 43.17 |
| 02:15 ET | 1363 | 43.21 |
| 02:18 ET | 900 | 43.2 |
| 02:20 ET | 1900 | 43.19 |
| 02:22 ET | 2009 | 43.16 |
| 02:24 ET | 1227 | 43.09 |
| 02:26 ET | 1900 | 43.01 |
| 02:27 ET | 6518 | 43.045 |
| 02:29 ET | 5994 | 42.9621 |
| 02:31 ET | 18060 | 42.92 |
| 02:33 ET | 14966 | 43.03 |
| 02:36 ET | 665 | 42.99 |
| 02:38 ET | 1950 | 42.92 |
| 02:40 ET | 5308 | 42.96 |
| 02:42 ET | 1200 | 43 |
| 02:44 ET | 2657 | 43.02 |
| 02:45 ET | 100 | 43.01 |
| 02:47 ET | 1200 | 42.92 |
| 02:49 ET | 25130 | 42.94 |
| 02:51 ET | 1100 | 42.955 |
| 02:54 ET | 713 | 42.95 |
| 02:56 ET | 1503 | 42.94 |
| 02:58 ET | 600 | 42.97 |
| 03:00 ET | 3226 | 42.92 |
| 03:02 ET | 2527 | 42.89 |
| 03:03 ET | 300 | 42.89 |
| 03:05 ET | 5321 | 42.84 |
| 03:07 ET | 1627 | 42.88 |
| 03:09 ET | 2200 | 42.92 |
| 03:12 ET | 8634 | 42.87 |
| 03:14 ET | 1353 | 42.83 |
| 03:16 ET | 2307 | 42.74 |
| 03:18 ET | 3452 | 42.8 |
| 03:20 ET | 2712 | 42.792 |
| 03:21 ET | 4946 | 42.69 |
| 03:23 ET | 1500 | 42.69 |
| 03:25 ET | 5968 | 42.76 |
| 03:27 ET | 1669 | 42.72 |
| 03:30 ET | 4343 | 42.73 |
| 03:32 ET | 5109 | 42.7795 |
| 03:34 ET | 4011 | 42.78 |
May 22, 2024
DJ Halozyme Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co., from 7:42AM ET on Wednesday May 22, 2024 by Dow Jones
7:42AM ET on Wednesday May 22, 2024 by Dow Jones
May 21, 2024
May 8, 2024
DJ Halozyme Therapeutics Is Maintained at Market Outperform by JMP Securities, from 2:09PM ET on Wednesday May 08, 2024 by Dow Jones
2:09PM ET on Wednesday May 08, 2024 by Dow JonesDJ Halozyme Therapeutics Currently Up Six Consecutive Days, On Track for Longest Winning Streak Since December 2022 -- Data Talk, from 11:02AM ET on Wednesday May 08, 2024 by Dow Jones
11:02AM ET on Wednesday May 08, 2024 by Dow JonesHalozyme to Participate in Upcoming Investor Conferences, from 8:30AM ET on Wednesday May 08, 2024 by Dow Jones
8:30AM ET on Wednesday May 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Halozyme Therapeutics Inc | 5.6B | 17.7x | --- |
Ionis Pharmaceuticals Inc | 5.4B | -14.1x | --- |
PTC Therapeutics Inc | 2.9B | -4.8x | --- |
Apellis Pharmaceuticals Inc | 4.9B | -11.8x | --- |
Intra-Cellular Therapies Inc | 6.9B | -56.8x | --- |
ACADIA Pharmaceuticals Inc | 2.5B | -1,168.2x | --- |
Company Information
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company’s ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, its commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with a focus on reducing treatment burden for patients. It also develops, manufactures, and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED, partnered commercial products and ongoing product development programs with several pharmaceutical companies. It markets and sells Hylenex recombinant, which is a formulation of rHuPH20. It markets and sells its proprietary product XYOSTED for SC administration of testosterone replacement therapy (TRT) in adult males.
Contact Information
- Headquarters
- 12390 EL CAMINO REALSAN DIEGO, CA, United States 92130
- Phone
- 858-794-8889
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Jeffrey Henderson
- President, Chief Executive Officer, Director
- Helen Torley
- Chief Financial Officer, Senior Vice President
- Nicole Labrosse
- Senior Vice President, Chief Technical Officer
- Michael Labarre
- Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
- Mark Snyder
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.6B |
|---|---|
Revenue (TTM) | $863.0M |
Shares Outstanding | 127.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $2.42 |
Book Value | $0.66 |
P/E Ratio | 17.7x |
Price/Sales (TTM) | 6.5 |
Price/Cash Flow (TTM) | 13.9x |
Operating Margin | 43.95% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
